Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | LOXL2 | Q9Y4K0 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.45 |
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
| ▸ | DAO | P14920 | 1/20 | 0.41 |
| ▸ | VCP | P55072 | 2/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL864772 | 0.90 | KDM4E (0.46) | KDM4ELOXL2CYP1A2CYP2A6KIF11 | |
| SCHEMBL11710173 | 0.87 | KDM4E (0.47) | KDM4ELOXL2CYP1A2CYP2A6KIF11 | |
| SCHEMBL28189651 | 0.87 | KDM4E (0.43) | KDM4ELOXL2CYP1A2CYP2A6KIF11 | |
| SCHEMBL8999779 | 0.80 | MAPT (0.57) | KDM4ECYP2A6MEN1KMT2ANPC1 | |
| SCHEMBL8296766 | 0.80 | LOXL2 (0.70) | KDM4ELOXL2DAOMEN1KMT2A | |
| SCHEMBL12829821 | 0.78 | AOC3 (0.48) | KDM4ECYP1A2CYP2A6KIF11DAO | |
| SCHEMBL27542164 | 0.78 | KDM4E (0.49) | KDM4ECYP1A2CYP2A6KIF11DAO | |
| SCHEMBL2056276 | 0.78 | LOXL2 (0.68) | KDM4ELOXL2DAOMEN1KMT2A | |
| SCHEMBL187518 | 0.78 | KDM4E (0.47) | KDM4ELOXL2DAOMAPTALDH1A1 | |
| SCHEMBL16440998 | 0.78 | CYP19A1 (0.47) | LOXL2CYP1A2CYP2A6VCPFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9701771-B2 | Substituted zirconocenes catalysts and methods of use in polymerization reactions | BASELL POLYOLEFINE GMBH (DE) | 2017-07-11 | — | — | US | disclosed |
| US-9622991-B2 | Hematopoietic growth factor mimetic small molecule compounds and their uses | LIGAND PHARMACEUTICALS INC. (US) | 2017-04-18 | — | — | US | disclosed |
| US-9593074-B2 | C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof | REATA PHARMACEUTICALS, INC. (US) | 2017-03-14 | — | — | US | disclosed |
| US-20160237051-A1 | EPOXIDATION CATALYSTS BASED ON METAL ALKOXIDE PRETREATED SUPPORTS | LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) | 2016-08-18 | — | — | US | disclosed |
| US-20160002279-A1 | COMPOUNDS FROM INVASIVE SALVINIAS AND METHODS OF USING THE SAME | STEPHEN F. AUSTIN STATE UNIVERSITY | 2016-01-07 | — | — | US | disclosed |
| US-20150284490-A1 | SUBSTITUTED ZIRCONOCENES CATALYSTS AND METHODS OF USE IN POLYMERIZATION REACTIONS | BASELL POLYOLEFIN GMBH (DE) | 2015-10-08 | — | — | US | disclosed |
| US-9144557-B2 | Hematopoietic growth factor mimetic small molecule compounds and their uses | LIGAND PHARMACEUTICALS INC. (US) | 2015-09-29 | — | — | US | disclosed |
| US-20150252043-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | CITIBANK, N.A., AS ADMINISTRATIVE AGENT | 2015-09-10 | — | — | US | disclosed |
| US-20140242135-A1 | COMPOSITIONS FOR INHIBITION OF INSECT SENSING | VANDERBILT UNIVERSITY (US) | 2014-08-28 | — | — | US | disclosed |
| US-20140243324-A1 | USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2014-08-28 | — | — | US | disclosed |
| US-20120276039-A1 | APTAMER-MODIFIED POLYMERIC MATERIALS FOR THE BINDING OF FACTORS IN A WOUND ENVIRONMENT | KCI LICENSING, INC. (US) | 2012-11-01 | — | — | US | disclosed |
| US-8293927-B2 | Efficient synthesis of morphine and codeine | BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-10-23 | — | — | US | disclosed |
| US-20120252776-A1 | C4 Monomethyl Triterpenoid Derivatives and Methods of Use Thereof | REATA PHARMACEUTICALS, INC. | 2012-10-04 | — | — | US | disclosed |
| US-20120101149-A1 | Betulinic Acid Derivatives and Methods of Use Thereof | REATA PHARMACEUTICALS, INC. | 2012-04-26 | — | — | US | disclosed |
| US-20120022012-A1 | Glycosylated Acetaminophen Pro-Drug Analogs | NuTek Pharma Ltd. | 2012-01-26 | — | — | US | disclosed |
| US-20110251246-A1 | SMALL MOLECULE INHIBITORS OF MUC1 AND METHODS OF IDENTIFYING THE SAME | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-10-13 | — | — | US | disclosed |
| US-20110196007-A1 | MONOCYCLIC CYANOENONES AND METHODS OF USE THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-08-11 | — | — | US | disclosed |
| US-7943778-B2 | Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives | REATA PHARMACEUTICALS, INC. (US) | 2011-05-17 | — | — | US | disclosed |
| US-20100292475-A1 | Efficient Synthesis Of Morphine And Codeine | BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM | 2010-11-18 | — | — | US | disclosed |
| US-20100041904-A1 | ANTIOXIDANT INFLAMMATION MODULATORS: C-17 HOMOLOGATED OLEANOLIC ACID DERIVATIVES | REATA PHARMACEUTICALS, INC. | 2010-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (14 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110196007-A1 | MONOCYCLIC CYANOENONES AND METHODS OF USE THEREOF | HSD17B7, HSD17B12, CYP11B2 | KDM4E 2521/4885LOXL2 1205/4885CYP1A2 219/4885 |
| US-20110251246-A1 | SMALL MOLECULE INHIBITORS OF MUC1 AND METHODS OF IDENTIFYING THE SAME | MUC1, EPCAM, CD44 | KDM4E 4817/4885LOXL2 1847/4885CYP1A2 4852/4885 |
| US-20140243324-A1 | USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS | HGF, EPOR, MPL | KDM4E 3484/4885LOXL2 3550/4885CYP1A2 4797/4885 |
| US-20160237051-A1 | EPOXIDATION CATALYSTS BASED ON METAL ALKOXIDE PRETREATED SUPPORTS | CYBB, AOX1, VKORC1 | KDM4E 115/4885LOXL2 95/4885CYP1A2 86/4885 |
| US-20150284490-A1 | SUBSTITUTED ZIRCONOCENES CATALYSTS AND METHODS OF USE IN POLYMERIZATION REACTIONS | MAOA, MPO, PARP1 | KDM4E 1471/4885LOXL2 217/4885CYP1A2 240/4885 |
| US-20100292475-A1 | Efficient Synthesis Of Morphine And Codeine | OPRK1, OPRM1, OPRL1 | KDM4E 534/4885LOXL2 3848/4885CYP1A2 101/4885 |
| US-20100041904-A1 | ANTIOXIDANT INFLAMMATION MODULATORS: C-17 HOMOLOGATED OLEANOLIC ACID DERIVATIVES | IL17A, ALOX15, ALOX12 | KDM4E 3290/4885LOXL2 411/4885CYP1A2 453/4885 |
| US-20150252043-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | MPL, CSF3R, HGF | KDM4E 1944/4885LOXL2 2355/4885CYP1A2 4846/4885 |
| US-20140242135-A1 | COMPOSITIONS FOR INHIBITION OF INSECT SENSING | OR51E2, TRPA1, OR10J3 | KDM4E 3619/4885LOXL2 3759/4885CYP1A2 3623/4885 |
| US-20120252776-A1 | C4 Monomethyl Triterpenoid Derivatives and Methods of Use Thereof | CYP4A11, LTC4S, NOX4 | KDM4E 1522/4885LOXL2 506/4885CYP1A2 205/4885 |
| US-20120101149-A1 | Betulinic Acid Derivatives and Methods of Use Thereof | BET1, PGGT1B, CYP3A5 | KDM4E 1796/4885LOXL2 1532/4885CYP1A2 79/4885 |
| US-20120276039-A1 | APTAMER-MODIFIED POLYMERIC MATERIALS FOR THE BINDING OF FACTORS IN A WOUND ENVIRONMENT | SDF4, CXCL12, PCLAF | KDM4E 4108/4885LOXL2 2876/4885CYP1A2 4863/4885 |
| US-20120022012-A1 | Glycosylated Acetaminophen Pro-Drug Analogs | UGT1A3, GCG, UGT1A1 | KDM4E 4019/4885LOXL2 2594/4885CYP1A2 34/4885 |
| US-20160002279-A1 | COMPOUNDS FROM INVASIVE SALVINIAS AND METHODS OF USING THE SAME | MMP8, GUSB, MMP9 | KDM4E 2849/4885LOXL2 1045/4885CYP1A2 1418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.